Bronya J. Keats Research Collaboration Award supports research teams working together on Friedreich’s ataxia projects no group could achieve alone, with the goal of advancing therapeutic development.
Funder: Friedreich's Ataxia Research Alliance
Due Dates (Anticipated): February 2027 (LOI) | April 2027 (Application)
Funding Amounts: Up to $175,000 USD per year for one or two years; up to one award annually
Summary: Supports collaborative Friedreich’s ataxia research whose goals cannot be achieved by any participating group alone.
Key Information: Investigators must collaborate across at least two different institutions, with synergy essential to project success.
The Bronya J. Keats Research Collaboration Award is administered by the Friedreich’s Ataxia Research Alliance (FARA) to support collaborative research on Friedreich’s ataxia (FA). It sits within FARA’s competitive research program spanning basic research, preclinical drug development, and clinical research, with the goal of advancing therapeutic development for FA.
The award focuses on projects in which collaboration is fundamental rather than incidental: participating groups must pursue research goals that no single group could accomplish independently. International collaborations and projects bringing new scientists into the FA research community receive special consideration. The award honors Bronya J. Keats for her academic work on the GAA triplet repeat mutation in FA and her continued role in managing FARA’s grant program.